In cancer-cachexia rats, treatment with formoterol did not significantly modify protein SOD1, SOD2, or catalase levels in either diaphragm or gastrocnemius muscles (Figs. 2A–2C and Figs. S6–S8). The gene discussed is CAT; the disease is cancer.